The European Commission's New Merger Guidelines: What Has Changed and Why It Matters
_<->1708724263995_9Y10OskXA8FdggLg.jpeg?w=3840&q=75){kind=small}
Sarah J
Posted on Wed, May 27, 2026
Share the article with your network
The European Commission published draft guidelines in late April 2026 that will replace two separate frameworks governing EU merger reviews for over two decades. The 2004 horizontal merger guidelines and the 2008 non-horizontal merger guidelines are both being retired in favour of a unified document applying the same analytical framework to all concentration types. The consultation period runs until 26 June 2026.
Why the rewrite now
The timing is not accidental. The Commission's opening sections are explicit about what has driven the revision: the global geopolitical and trade environment has shifted considerably since 2004, and the previous guidelines did not adequately reflect the weight that scale, innovation and supply chain resilience should carry in merger analysis. Europe has watched American and Chinese firms consolidate to sizes that European companies, restrained by domestic antitrust thinking, have struggled to match.
The document states that industrial scale and global competitiveness have become increasingly important, and that the economy has shifted towards more innovation-heavy sectors with greater reliance on critical supply chains where scale, innovation and securing reliable access to inputs may be critical to compete. Future assessments will give more weight to these factors as procompetitive considerations, not merely as efficiency claims that counteract established harm.
The core legal test stays the same
The standard for blocking a merger remains the "significant impediment to effective competition" test under Council Regulation (EC) No 139/2004. The Commission examines whether a merger results in a SIEC in the internal market or a substantial part of it, in particular as a result of the creation or strengthening of a dominant position. What changes is the analytical lens applied to that test, particularly how benefits are weighed against harm and how innovation, dynamic effects and resilience are treated as competitive parameters rather than background considerations.
Importantly, the expanded toolkit works in both directions. The guidelines elaborate the theories of harm as well as benefit, covering foreclosure, entrenchment of dominance, loss of potential competition, and coordination effects alongside the scale and innovation arguments that will attract deal teams' attention.
Static versus dynamic assessment
One structural shift worth noting is the explicit elevation of dynamic and long-term effects alongside the traditional static price analysis. The assessment should consider dynamic aspects and long-term impact where appropriate, including how a transaction affects future innovation potential, investment incentives and competitive dynamics over time. This matters because many deals in technology, pharmaceuticals, energy transition and defence turn less on current market shares than on who controls the next generation of capabilities.
Scale-enhancing mergers get more explicit support
One of the most commercially significant shifts in the new guidelines is the explicit endorsement of mergers that help European firms reach the size needed to compete internationally. The Commission regards positively mergers that increase procompetitive scale while maintaining effective competition in the internal market, particularly in markets where global firms play a significant role and exert significant competitive pressure.
The guidelines set out specific categories where scale-enhancing deals are viewed favourably: mergers that produce R&D synergies enabling projects that would not otherwise be feasible, deals that combine complementary capabilities from different member states without generating significant overlaps, acquisitions that accelerate access to scarce talent or critical resources, transactions that strengthen supply chain resilience, and deals supporting European defence readiness including security of supply. That said, the Commission remains clear that scale serving competitiveness must be distinguished from scale that entrenches market power or forecloses rivals.
Innovation gets treated as a competition parameter
The previous frameworks largely treated innovation as something to be protected from harm or claimed as an efficiency offset. The new guidelines integrate innovation directly into the competitive assessment, both as a source of harm and as a basis for benefit claims. When the Commission constructs a theory of harm, it must consider whether the merger reduces innovation competition, not just price competition. This means deal parties can frame their theory of benefit around innovation effects, arguing that a merger enables R&D at a scale or pace that neither party could achieve independently.
The document introduces an "innovation shield" concept, located within the loss of innovation competition section, which allows a deal to be assessed more favourably where it credibly protects or enables genuine innovation potential in cases where a more static analysis might otherwise raise concern. This is a real new tool, though it applies within a specific analytical context rather than functioning as a broad defensive argument for any transaction.
Resilience and sustainability are now competition parameters
Non-price competition can encompass a variety of parameters including output, quality, choice, capacity, investment, innovation, privacy, sustainability, and resilience including security of supply. Adding resilience and sustainability to this list formally means that mergers which strengthen supply chains, reduce dependencies on single-source inputs, or advance green technology transitions can now be assessed differently than under the old frameworks, where these considerations had limited formal standing in the competitive analysis itself.
The burden of proof framework
The Commission bears the burden of establishing that a merger is more likely than not to result in a SIEC. Merging parties bear the burden of demonstrating any alleged efficiencies stemming from the merger that could counteract its anticompetitive effects. To claim efficiencies, parties must set out a "theory of benefit" explaining concretely how the merger leads to lower prices, greater innovation, improved quality, or other consumer gains that durably offset harm. The Commission is encouraging early engagement on this, including during pre-notification.
A higher threshold applies where market power is significant. The more market power the merged entity holds, especially in a dominant position, the less likely it is that efficiencies will be sufficient to outweigh competitive harm. It is highly unlikely that a merger leading to a market position approaching that of a monopoly will result in efficiencies that sufficiently outweigh the harm.
Member state powers and legitimate interests
The new guidelines also clarify how member states can invoke Article 21(4) of the EUMR to block or impose conditions on mergers that the Commission might otherwise clear. This provision allows national governments to act on legitimate interests beyond competition, such as media plurality, public security and financial stability. The guidelines set out what qualifies as a legitimate interest and the proportionality requirements that apply, addressing a procedural area that has generated litigation in recent years.
What this means in practice
For deal teams and their advisers, the new framework opens more room to build procompetitive narratives around scale, innovation and resilience, particularly for cross-border European consolidations in sectors like defence, critical materials, clean technology and digital infrastructure. Companies can and should engage earlier in the process on their theory of benefit, especially in deals where innovation or supply chain arguments are central. At the same time, the Commission has not relaxed its grip on dominance. Expanded theories of harm, including foreclosure, entrenchment and portfolio effects, sit alongside the new procompetitive language. The message is that consolidation serving European competitiveness is welcome, but market power for its own sake remains squarely in scope.
The guidelines apply to mergers notified after the formal adoption date, which remains a placeholder in the current draft pending conclusion of the consultation.
Refer the full report here: https://competition-policy.ec.europa.eu/document/download/46dde10f-85c1-4590-a3f4-2b71f85685ef_en?filename=Merger%20Guidelines%20-%20final%20for%20public%20consultation.pdf
You may also like
Sarah J
Fri, May 22, 2026
Andhra Pradesh Is Competing With Tamil Nadu's Manufacturing With Faster Processing
Sarah J
Fri, May 22, 2026
GOOGLE I/O 2026: EVERYTHING ANNOUNCED, EXPLAINED
Sarah J
Fri, May 22, 2026
Indian Rupees Under Pressure - A Perfect Storm of Geopolitics and Weak Flows
